4.8 Article

FHL2 interacts with EGFR to promote glioblastoma growth

Related references

Note: Only part of the references are listed.
Article Neurosciences

Control of glioblastoma tumorigenesis by feed-forward cytokine signaling

Arezu Jahani-Asl et al.

NATURE NEUROSCIENCE (2016)

Article Oncology

Epidermal growth factor receptor targeting and challenges in glioblastoma

Amy Haseley Thorne et al.

NEURO-ONCOLOGY (2016)

Review Oncology

Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma

Emily Padfield et al.

FRONTIERS IN ONCOLOGY (2015)

Article Biochemistry & Molecular Biology

EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma

L. Li et al.

ONCOGENE (2015)

Article Biochemistry & Molecular Biology

LIM-Only Protein FHL2 Activates NF-κB Signaling in the Control of Liver Regeneration and Hepatocarcinogenesis

Jennifer Dahan et al.

MOLECULAR AND CELLULAR BIOLOGY (2013)

Article Immunology

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas

Catherine A. Del Vecchio et al.

EXPERT REVIEW OF VACCINES (2012)

Article Gastroenterology & Hepatology

The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis

Yann Nouet et al.

JOURNAL OF HEPATOLOGY (2012)

Article Biochemistry & Molecular Biology

LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII

M. A. Stutz et al.

ONCOGENE (2008)

Article Multidisciplinary Sciences

The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways

Charlotte Labalette et al.

PLOS ONE (2008)

Review Cell Biology

Malignant astrocytic glioma: genetics, biology, and paths to treatment

Frank B. Furnari et al.

GENES & DEVELOPMENT (2007)

Article Multidisciplinary Sciences

Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction

Jens Fielitz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins

G. C. Davies et al.

ONCOGENE (2006)

Article Oncology

Mouse models of brain tumors and their applications in preclinical trials

Elena I. Fomchenko et al.

CLINICAL CANCER RESEARCH (2006)

Article Biochemistry & Molecular Biology

The LIM-only protein FHL2 is a negative regulator of E4F1

C. Paul et al.

ONCOGENE (2006)

Article Obstetrics & Gynecology

Expression of the transcriptional coregulator FHL2 in human breast cancer: A clinicopathologic study

B Gabriel et al.

JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION (2006)

Article Biochemical Research Methods

Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells

A Thelemann et al.

MOLECULAR & CELLULAR PROTEOMICS (2005)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Biochemistry & Molecular Biology

FHL2 (SLIM3) is not essential for cardiac development and function

PH Chu et al.

MOLECULAR AND CELLULAR BIOLOGY (2000)